This is an Insight article, written by a selected contributor as part of WTR's co-published content. Read more on Insight In an innovation-driven economy, intangible assets such as patents, trademarks ...
Here are reviews of five of the best available books on blockchain, a relatively new, but rapidly growing and very important ...
This represents a 50% jump from its $6 billion valuation achieved seven months ago, signaling investor confidence in AI ...
Wegovy pill introduction in the U.S. may serve as the turning point that transforms a beleaguered GLP‑1 leader into a viable ...
An expert Q&A on the valuation of digital assets and other key issues within the evolving cryptocurrency landscape, including ...
RH is demonstrating resilient demand and topline growth despite a historically weak US housing market, without resorting to ...
Investors Believe Overvaluation Is One of the Biggest Risks to the AI Story. Here Are 2 AI Stocks With the Frothiest ...
Hexagon AB stock remains a BUY as operations recover and cash conversion stays strong—see growth outlook, divestiture impact, ...
Florida has taken a major step toward becoming a sovereign leader in the digital asset space with the introduction of House ...
SOFI is up 40% in six months as new payments, crypto and AI launches fuel growth, but a premium valuation raises questions on ...
A Year Of Quiet Progress: How Tariffs And AI Shaped M&A In 2025 And What To Expect In The Year Ahead
As 2026 approaches, dealmakers face a dual challenge: balancing macro uncertainty with the transformative potential of the ...
Eli Lilly has the lead in the GLP-1 race, but Novo Nordisk just changed the game.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results